$KITE Headlines S&P 500 ends higher for first-ever

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$KITE Headlines

S&P 500 ends higher for first-ever close above 2,000 3:32 p.m. Aug. 26, 2014 - Victor Reklaitis
Google buys Zync; Mobileye rallies, Orbitz falls 2:34 p.m. Aug. 26, 2014 - Angela Johnson
Kite Pharma shares fly high on study results 4:47 p.m. Aug. 25, 2014 - Wallace Witkowski
Kite Pharma shares surge 49% on drug study result 3:50 p.m. Aug. 25, 2014 - Wallace Witkowski

Cellectis Is Late To The CAR-T Cell Race, But Could Finish First 4:21 p.m. Jan. 2, 2015 - Seeking Alpha
UPDATE: Credit Suisse Raises PT On Kite Pharma On Strong Outlook For CAR-T 6:58 a.m. Jan. 2, 2015 - benzinga.com
Health Care IPO Filings Moving Into A Busy New Year 3:04 p.m. Dec. 31, 2014 - Investors Business Daily
Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog 5:20 p.m. Dec. 29, 2014 - Zacks.com
7 Best Performing IPOs of Record-Breaking 2014 - Analyst Blog 9:41 a.m. Dec. 29, 2014 - Zacks.com
Alibaba Helps Boost IPO Market To Top Year Since 2010 2:46 p.m. Dec. 24, 2014 - Investors Business Daily
Alibaba Tops The 5 Most Watched IPOs In Booming 2014 1:47 p.m. Dec. 24, 2014 - Investors Business Daily
Kite Pharma submits IND for blood cancer candidate 1:26 p.m. Dec. 22, 2014 - Seeking Alpha
Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market 6:14 a.m. Dec. 22, 2014 - TheStreet.com
Cramer's Mad Money - Look At Red Hat Go (12/19/14) 5:26 a.m. Dec. 21, 2014 - Seeking Alpha
Juno Therapeutics IPO Hot As Cancer Curers In Demand 5:32 p.m. Dec. 19, 2014 - Investors Business Daily
Juno Therapeutics IPO Caps Big Year In Biotech Deals 11:47 a.m. Dec. 19, 2014 - Investors Business Daily
Bellicum Leaps On Biotech IPO, Setting Stage For Juno 11:44 a.m. Dec. 18, 2014 - Investors Business Daily
Juno Therapeutics: Saving The Best Biotech IPO For Last In 2014 11:13 a.m. Dec. 17, 2014 - Seeking Alpha
Juno Therapeutics Ups IPO Price In Hot Biotech Field 1:46 p.m. Dec. 16, 2014 - Investors Business Daily
IPO Calendar: Year Wrapping Up With Juno, OnDeck IPOs 4:46 p.m. Dec. 15, 2014 - Investors Business Daily
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Cramer's Mad Money - The Good Isis (12/10/14) 4:43 a.m. Dec. 11, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Good News-Bad News of Lower Oil Prices 8:41 p.m. Dec. 10, 2014 - TheStreet.com
Kite Pharma Breaks Out, Again 10:41 a.m. Dec. 10, 2014 - benzinga.com


Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 8:31 a.m. Dec. 30, 2014 - GlobeNewswire
Kite Pharma Submits Investigational New Drug Application for Phase 1/2 Trial of KTE-C19, Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, for the Treatment of Refractory Aggressive Non-Hodgkin Lymphoma 12:40 p.m. Dec. 22, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Follow-On Offering 9:01 p.m. Dec. 10, 2014 - GlobeNewswire
BioPharm Insight Releases Hematological Cancer Report in Advance of American Society of Hematology (ASH) Annual Meeting Next Month 2:19 p.m. Nov. 24, 2014 - BusinessWire - BZX
Kite Pharma Announces Presentations at the Upcoming 56th American Society of Hematology Annual Meeting 8:01 a.m. Nov. 18, 2014 - GlobeNewswire
Could This Emerging Drug Developer Really Be Worth A Billion Dollars In Five Years? 8:03 a.m. Nov. 17, 2014 - ACCESSWIRE
Kite Pharma Receives Positive Opinion for Orphan Drug Designation in the European Union for KTE-C19, Kite's Lead Investigational Cancer Immunotherapy 8:02 a.m. Nov. 17, 2014 - GlobeNewswire
Kite Pharma Reports Third Quarter 2014 Results 3:20 p.m. Nov. 14, 2014 - GlobeNewswire
Kite Pharma to Participate in Three Upcoming Investor Conferences in November 2014 8:05 a.m. Nov. 5, 2014 - GlobeNewswire
Kite Pharma Announces Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells 7:01 a.m. Oct. 13, 2014 - GlobeNewswire
Kite Pharma to Participate in Gene Therapy Panel at the BIO Investor Forum 5:31 p.m. Oct. 3, 2014 - GlobeNewswire
Kite Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26 11:56 a.m. Sept. 16, 2014 - GlobeNewswire
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 7:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Kite Pharma Announces Patients With Aggressive Non-Hodgkin's Lymphoma Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells at the National Cancer Institute (NCI) 3:31 p.m. Aug. 25, 2014 - GlobeNewswire
Kite Pharma Reports Second Quarter 2014 Results 4:41 p.m. Aug. 14, 2014 - GlobeNewswire
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 6:31 a.m. June 23, 2014 - GlobeNewswire
Kite Pharma, Inc. (NASDAQ: KITE) to Ring The NASDAQ Stock Market Closing Bell 9:01 a.m. June 20, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Initial Public Offering 5:00 a.m. June 20, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 2

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 6

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 0

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 2

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 3

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 67

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Samsung Partners with AI Innovators for Galaxy S26 Launch

Updated Category News Views 234

Samsung’s Ambitious AI Integration for Galaxy S26 Samsung Electronics SSNLF is actively pursuing partnerships with OpenAI and Perplexity AI as it strives to incorporate a wider array of artificial intelligence capabilities into its next-generation Galaxy devices. The company's intent is to diversify its AI services, significantly reducing its previous dependency on...

Continue Reading
Orion Corporation's Recent Share Transactions by Eija Ronkainen

Updated Category News Views 151

Overview of Managers' Transactions at Orion Corporation Orion Corporation is committed to transparency and accountability in its operations. Recently, a disclosure was made concerning share transactions involving Eija Ronkainen, a notable member of the company's Board. This transaction is governed by the Market Abuse Regulation (EU) No 596/2014. Details of the Disclosure...

Continue Reading
Essity Reports Strong Performance Amid Economic Challenges

Updated Category News Views 215

Continuous Growth and Resilience in Tough Times Essity's recent interim report for the second quarter of 2025 showcases the company's ability to navigate through economic headwinds while maintaining a focus on growth and innovation. Even with a challenging economic backdrop, Essity demonstrated a stronger financial performance, indicating a commitment to both its...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit from Shareholders

Updated Category News Views 132

Lantheus Holdings and the Class Action Lawsuit Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently embroiled in a securities fraud class action lawsuit that has garnered attention from investors. This development comes after a shareholder filed a suit on behalf of those who acquired shares of the company between specific dates in 2025. Details of the Lawsuit The lawsuit...

Continue Reading
Ménage à Trois Introduces New Low-Calorie White Wine

Updated Category News Views 154

Ménage à Trois Introduces Light Sauvignon Blanc Fresh and flavorful, the Light Sauvignon Blanc from Ménage à Trois is set to delight consumers while catering to the growing demand for low-alcohol wines. With only 90 calories and 8% alcohol by volume, this new addition reflects the brand's commitment to providing products that align with modern lifestyles. Expanding...

Continue Reading